{
    "title": "Roche's Alecensa wins EU panel's nod against mutated lung cancer",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4977538/Roches-Alecensa-wins-EU-panels-nod-against-mutated-lung-cancer.html",
    "date": "2017-10-13",
    "keywords": [
        "alecensa",
        "lung",
        "cancer",
        "drug",
        "approval",
        "firstline",
        "roche",
        "miller",
        "chmp",
        "ocrevus",
        "drugmaker",
        "europe",
        "treatment",
        "agency",
        "panel",
        "patent",
        "analyst",
        "percent",
        "market",
        "committee",
        "use",
        "monotherapy",
        "alk",
        "nonsmall",
        "cell",
        "commission",
        "risk",
        "disease",
        "spreading",
        "brain",
        "standard",
        "care",
        "trial",
        "race",
        "novartis",
        "zykadia",
        "alunbrig",
        "priority",
        "review",
        "food",
        "administration",
        "august",
        "year",
        "sclerosis",
        "medicine",
        "release",
        "friday",
        "factor",
        "decision",
        "july",
        "growth",
        "reporting",
        "john",
        "editing"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}